Biotechnology
The Biotechnology industry has a total of 605 stocks, with a combined market cap of $1.1 trillion and total revenue of $105.41 billion.
Market Cap
1.1T
Revenue
105.41B
Profits
-41.76B
PE Ratio
n/a
Profit Margin
-39.62%
Dividend Yield
0.04%
605 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 114.71B | -0.27% | 824,668 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 79.65B | 0.58% | 464,686 | 14.25B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 52.87B | 0.63% | 730,355 | 3.21B |
| 4 | ARGX | argenx SE | 52.03B | -0.11% | 216,114 | 3.68B |
| 5 | INSM | Insmed Incorporated | 37.77B | 1.77% | 1,831,419 | 447.02M |
| 6 | ONC | BeOne Medicines AG | 34.42B | 2.37% | 187,188 | 4.97B |
| 7 | BNTX | BioNTech SE | 23.25B | 1.57% | 663,556 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 22.43B | 0.57% | 3,202,276 | 2.35B |
| 9 | INCY | Incyte Corporation | 19.91B | 2.68% | 2,152,162 | 4.81B |
| 10 | GMAB | Genmab A/S | 19.44B | 3.31% | 1,831,714 | 3.85B |
| 11 | RVMD | Revolution Medicines, Inc. | 15.28B | -0.79% | 1,381,436 | - |
| 12 | ROIV | Roivant Sciences Ltd. | 15.25B | 1.06% | 6,881,314 | 20.33M |
| 13 | BBIO | BridgeBio Pharma, Inc. | 15.08B | 2.28% | 2,413,435 | 353.78M |
| 14 | SMMT | Summit Therapeutics Inc. | 13.51B | 0.17% | 1,416,994 | - |
| 15 | MDGL | Madrigal Pharmaceuticals, Inc. | 13.49B | 1.98% | 281,988 | 740.64M |
| 16 | ASND | Ascendis Pharma A/S | 13.03B | 0.02% | 343,338 | 758.59M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.90B | 0.71% | 1,400,449 | 966.96M |
| 18 | MRNA | Moderna, Inc. | 12.06B | 4.65% | 9,582,428 | 2.23B |
| 19 | EXEL | Exelixis, Inc. | 11.73B | -0.57% | 2,489,379 | 2.29B |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 11.42B | 0.03% | 1,143,221 | 3.09B |
| 21 | RNA | Avidity Biosciences, Inc. | 10.86B | -0.04% | 2,805,782 | 20.87M |
| 22 | JAZZ | Jazz Pharmaceuticals plc | 10.52B | 1.85% | 821,781 | 4.16B |
| 23 | ABVX | ABIVAX Société Anonyme | 10.51B | -0.81% | 978,098 | 6.23M |
| 24 | TECH | Bio-Techne Corporation | 9.29B | 1.43% | 1,941,684 | 1.22B |
| 25 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.21B | 2.11% | 1,161,322 | 829.45M |
| 26 | AXSM | Axsome Therapeutics, Inc. | 9.01B | -2.16% | 1,431,499 | 561.26M |
| 27 | HALO | Halozyme Therapeutics, Inc. | 8.27B | 4.47% | 2,841,279 | 1.24B |
| 28 | NUVL | Nuvalent, Inc. | 7.83B | 0.29% | 492,504 | - |
| 29 | CAI | Caris Life Sciences, Inc. | 7.61B | - | 1,864,039 | 649.06M |
| 30 | CYTK | Cytokinetics, Incorporated | 7.55B | -2.85% | 1,879,157 | 87.21M |
| 31 | PRAX | Praxis Precision Medicines, Inc. | 7.16B | -2.83% | 364,618 | 7.46M |
| 32 | KRYS | Krystal Biotech, Inc. | 7.16B | 0.15% | 193,508 | 373.16M |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.01B | -1.90% | 392,560 | 174.33M |
| 34 | CDTX | Cidara Therapeutics, Inc. | 6.96B | 0.06% | 1,423,339 | 302.00K |
| 35 | PTCT | PTC Therapeutics, Inc. | 6.16B | 1.03% | 768,334 | 1.78B |
| 36 | PCVX | Vaxcyte, Inc. | 6.08B | 0.69% | 834,690 | - |
| 37 | BLTE | Belite Bio, Inc | 5.97B | -0.43% | 242,027 | - |
| 38 | KYMR | Kymera Therapeutics, Inc. | 5.82B | -6.49% | 854,004 | 43.74M |
| 39 | PTGX | Protagonist Therapeutics, Inc. | 5.45B | -0.18% | 751,656 | 209.22M |
| 40 | COGT | Cogent Biosciences, Inc. | 5.28B | -2.20% | 2,580,779 | - |
| 41 | IMVT | Immunovant, Inc. | 5.25B | 1.93% | 1,733,961 | - |
| 42 | CRSP | CRISPR Therapeutics AG | 5.12B | 2.54% | 1,372,955 | 38.34M |
| 43 | APGE | Apogee Therapeutics, Inc. | 5.11B | 0.40% | 943,187 | - |
| 44 | GPCR | Structure Therapeutics Inc. | 4.71B | -2.06% | 920,391 | - |
| 45 | CELC | Celcuity Inc. | 4.65B | 0.81% | 594,201 | - |
| 46 | ACAD | ACADIA Pharmaceuticals Inc. | 4.45B | -1.57% | 1,666,152 | 1.05B |
| 47 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.43B | 0.39% | 680,121 | 1.54M |
| 48 | FOLD | Amicus Therapeutics, Inc. | 4.40B | 0.21% | 8,082,780 | 598.70M |
| 49 | SRRK | Scholar Rock Holding Corporation | 4.37B | -2.84% | 865,455 | - |
| 50 | TERN | Terns Pharmaceuticals, Inc. | 4.36B | -0.72% | 1,783,516 | - |
| 51 | TGTX | TG Therapeutics, Inc. | 4.28B | -1.78% | 2,107,713 | 531.90M |
| 52 | ADMA | ADMA Biologics, Inc. | 4.26B | -1.97% | 1,973,233 | 488.56M |
| 53 | CORT | Corcept Therapeutics Incorporated | 4.02B | 9.77% | 6,702,841 | 741.17M |
| 54 | MIRM | Mirum Pharmaceuticals, Inc. | 4.01B | -1.16% | 1,708,773 | 471.79M |
| 55 | VKTX | Viking Therapeutics, Inc. | 4.00B | 0.68% | 1,845,031 | - |
| 56 | NAMS | NewAmsterdam Pharma Company N.V. | 3.99B | 0.34% | 991,018 | 35.24M |
| 57 | LEGN | Legend Biotech Corporation | 3.97B | -1.06% | 1,419,008 | 909.05M |
| 58 | LGND | Ligand Pharmaceuticals Incorporated | 3.74B | 0.37% | 170,882 | 251.23M |
| 59 | ACLX | Arcellx, Inc. | 3.66B | -2.85% | 668,453 | 35.90M |
| 60 | ARQT | Arcutis Biotherapeutics, Inc. | 3.55B | -0.14% | 1,652,786 | 317.93M |
| 61 | TVTX | Travere Therapeutics, Inc. | 3.54B | 3.43% | 1,729,529 | 435.83M |
| 62 | CNTA | Centessa Pharmaceuticals plc | 3.46B | -5.28% | 783,708 | 15.00M |
| 63 | VERA | Vera Therapeutics, Inc. | 3.45B | -3.99% | 1,031,183 | - |
| 64 | XENE | Xenon Pharmaceuticals Inc. | 3.44B | -0.74% | 1,166,387 | 7.50M |
| 65 | TARS | Tarsus Pharmaceuticals, Inc. | 3.43B | -1.66% | 619,254 | 366.10M |
| 66 | CGON | CG Oncology, Inc. | 3.37B | 0.65% | 1,053,936 | 2.17M |
| 67 | APLS | Apellis Pharmaceuticals, Inc. | 3.27B | 2.95% | 3,275,000 | 1.02B |
| 68 | DYN | Dyne Therapeutics, Inc. | 3.05B | -5.42% | 2,653,787 | - |
| 69 | IRON | Disc Medicine, Inc. | 2.99B | -0.40% | 329,148 | - |
| 70 | IDYA | IDEAYA Biosciences, Inc. | 2.97B | -2.08% | 594,165 | 214.83M |
| 71 | NUVB | Nuvation Bio Inc. | 2.94B | -4.24% | 5,326,478 | 26.75M |
| 72 | VRDN | Viridian Therapeutics, Inc. | 2.93B | -1.41% | 1,060,180 | 70.79M |
| 73 | WVE | Wave Life Sciences Ltd. | 2.92B | -6.18% | 2,867,454 | 109.23M |
| 74 | RCUS | Arcus Biosciences, Inc. | 2.88B | -2.27% | 1,026,380 | 240.00M |
| 75 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.85B | -0.81% | 820,288 | 578.20M |
| 76 | MLYS | Mineralys Therapeutics, Inc. | 2.83B | -1.60% | 914,344 | - |
| 77 | LQDA | Liquidia Corporation | 2.73B | -8.96% | 2,881,869 | 69.22M |
| 78 | BEAM | Beam Therapeutics Inc. | 2.68B | -2.09% | 1,348,448 | 55.70M |
| 79 | TLX | Telix Pharmaceuticals Limited | 2.57B | 1.74% | 133,185 | 664.23M |
| 80 | DNLI | Denali Therapeutics Inc. | 2.54B | -1.45% | 1,185,493 | - |
| 81 | SLNO | Soleno Therapeutics, Inc. | 2.53B | 1.88% | 1,767,590 | 98.68M |
| 82 | OCUL | Ocular Therapeutix, Inc. | 2.52B | -2.64% | 2,499,105 | 55.78M |
| 83 | EWTX | Edgewise Therapeutics, Inc. | 2.51B | -4.29% | 1,002,858 | - |
| 84 | ADPT | Adaptive Biotechnologies Corporation | 2.43B | -2.03% | 1,060,400 | 252.75M |
| 85 | AAPG | Ascentage Pharma Group International | 2.40B | 2.48% | 2,331 | 54.52M |
| 86 | MESO | Mesoblast Limited | 2.38B | 0.67% | 193,301 | 17.20M |
| 87 | SYRE | Spyre Therapeutics, Inc. | 2.37B | -6.65% | 888,689 | - |
| 88 | IMNM | Immunome, Inc. | 2.30B | -3.07% | 2,108,717 | 9.68M |
| 89 | RARE | Ultragenyx Pharmaceutical Inc. | 2.27B | 2.61% | 3,639,892 | 630.60M |
| 90 | SRPT | Sarepta Therapeutics, Inc. | 2.23B | -0.98% | 1,895,856 | 2.41B |
| 91 | RXRX | Recursion Pharmaceuticals, Inc. | 2.19B | 2.69% | 16,224,715 | 43.69M |
| 92 | GLPG | Galapagos NV | 2.18B | 0.84% | 72,129 | 336.64M |
| 93 | HRMY | Harmony Biosciences Holdings, Inc. | 2.15B | -0.11% | 522,130 | 825.94M |
| 94 | AUPH | Aurinia Pharmaceuticals Inc. | 2.02B | -3.76% | 1,674,993 | 265.81M |
| 95 | ZYME | Zymeworks Inc. | 1.99B | 1.10% | 589,258 | 134.48M |
| 96 | IBRX | ImmunityBio, Inc. | 1.99B | 2.02% | 10,371,960 | 82.56M |
| 97 | OLMA | Olema Pharmaceuticals, Inc. | 1.99B | 1.12% | 913,547 | - |
| 98 | ZLAB | Zai Lab Limited | 1.93B | -1.76% | 758,737 | 441.63M |
| 99 | MAZE | Maze Therapeutics, Inc. | 1.91B | -4.01% | 436,645 | 2.50M |
| 100 | ZBIO | Zenas BioPharma, Inc. | 1.85B | -4.98% | 201,613 | 15.00M |
| 101 | SNDX | Syndax Pharmaceuticals, Inc. | 1.85B | 1.38% | 1,096,380 | 111.30M |
| 102 | NRIX | Nurix Therapeutics, Inc. | 1.83B | -4.80% | 1,469,707 | 83.69M |
| 103 | VCEL | Vericel Corporation | 1.80B | -1.11% | 486,062 | 258.72M |
| 104 | CLDX | Celldex Therapeutics, Inc. | 1.79B | -0.55% | 1,005,062 | 2.60M |
| 105 | STOK | Stoke Therapeutics, Inc. | 1.76B | -2.65% | 645,854 | 205.63M |
| 106 | SION | Sionna Therapeutics, Inc. | 1.75B | -4.69% | 318,896 | - |
| 107 | PHVS | Pharvaris N.V. | 1.72B | -4.58% | 240,940 | - |
| 108 | MNKD | MannKind Corporation | 1.72B | -1.23% | 2,730,430 | 313.79M |
| 109 | IMCR | Immunocore Holdings plc | 1.71B | -2.68% | 239,849 | 379.59M |
| 110 | DNTH | Dianthus Therapeutics, Inc. | 1.70B | -3.71% | 617,230 | 3.08M |
| 111 | KOD | Kodiak Sciences Inc. | 1.59B | -6.94% | 933,271 | - |
| 112 | AGIO | Agios Pharmaceuticals, Inc. | 1.58B | -0.15% | 947,024 | 44.79M |
| 113 | FTRE | Fortrea Holdings Inc. | 1.55B | -2.55% | 1,178,056 | 2.76B |
| 114 | TRVI | Trevi Therapeutics, Inc. | 1.52B | -5.03% | 1,525,544 | - |
| 115 | PGEN | Precigen, Inc. | 1.51B | 2.39% | 2,774,292 | 6.31M |
| 116 | ARDX | Ardelyx, Inc. | 1.49B | 5.49% | 8,275,719 | 398.23M |
| 117 | INVA | Innoviva, Inc. | 1.49B | -0.60% | 453,489 | 388.52M |
| 118 | CAPR | Capricor Therapeutics, Inc. | 1.46B | -1.91% | 1,335,665 | 11.13M |
| 119 | UPB | Upstream Bio, Inc. | 1.46B | -0.29% | 586,434 | 2.80M |
| 120 | QURE | uniQure N.V. | 1.46B | -2.26% | 936,060 | 15.75M |
| 121 | EYPT | EyePoint, Inc. | 1.45B | -4.32% | 775,975 | 42.34M |
| 122 | BHVN | Biohaven Ltd. | 1.44B | -3.99% | 2,108,191 | - |
| 123 | TSHA | Taysha Gene Therapies, Inc. | 1.44B | -4.55% | 2,358,997 | 6.31M |
| 124 | TYRA | Tyra Biosciences, Inc. | 1.43B | 1.90% | 793,775 | - |
| 125 | RLAY | Relay Therapeutics, Inc. | 1.42B | -3.31% | 1,566,721 | 8.36M |
| 126 | ATAI | Atai Beckley N.V. | 1.41B | -5.38% | 5,756,439 | 3.02M |
| 127 | MBX | MBX Biosciences, Inc. | 1.37B | -3.14% | 564,003 | - |
| 128 | ORKA | Oruka Therapeutics, Inc. | 1.37B | -6.73% | 492,396 | - |
| 129 | SVRA | Savara Inc. | 1.36B | -6.47% | 1,740,227 | - |
| 130 | MNMD | Mind Medicine (MindMed) Inc. | 1.34B | 1.87% | 1,663,481 | - |
| 131 | RAPP | Rapport Therapeutics, Inc. | 1.34B | -7.35% | 469,931 | - |
| 132 | IMTX | Immatics N.V. | 1.27B | -0.48% | 810,041 | 99.45M |
| 133 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.25B | -5.46% | 2,123,463 | -665.00K |
| 134 | SEPN | Septerna, Inc. | 1.25B | 0.36% | 255,610 | 22.05M |
| 135 | ANAB | AnaptysBio, Inc. | 1.24B | -7.28% | 498,093 | 169.47M |
| 136 | XERS | Xeris Biopharma Holdings, Inc. | 1.22B | -6.37% | 2,801,599 | 266.14M |
| 137 | TNGX | Tango Therapeutics, Inc. | 1.20B | 0.79% | 1,160,434 | 66.50M |
| 138 | PVLA | Palvella Therapeutics, Inc. | 1.19B | -4.19% | 328,466 | - |
| 139 | PHAR | Pharming Group N.V. | 1.18B | -2.60% | 31,331 | 362.27M |
| 140 | OMER | Omeros Corporation | 1.16B | -4.66% | 2,843,564 | - |
| 141 | NVAX | Novavax, Inc. | 1.16B | 6.10% | 3,888,886 | 1.06B |
| 142 | OCS | Oculis Holding AG | 1.16B | 0.04% | 62,167 | 992.00K |
| 143 | SPRY | ARS Pharmaceuticals, Inc. | 1.14B | -1.37% | 1,677,029 | 142.77M |
| 144 | SANA | Sana Biotechnology, Inc. | 1.12B | 2.95% | 1,491,837 | - |
| 145 | PHAT | Phathom Pharmaceuticals, Inc. | 1.09B | -5.30% | 708,784 | 147.19M |
| 146 | INBX | Inhibrx Biosciences, Inc. | 1.09B | -5.01% | 280,848 | 1.40M |
| 147 | NBTX | Nanobiotix S.A. | 1.08B | -4.28% | 56,610 | 11.93M |
| 148 | NTLA | Intellia Therapeutics, Inc. | 1.07B | 2.45% | 2,736,244 | 57.53M |
| 149 | XNCR | Xencor, Inc. | 1.07B | -2.55% | 603,192 | 150.13M |
| 150 | URGN | UroGen Pharma Ltd. | 1.06B | -3.03% | 437,136 | 96.52M |
| 151 | CVAC | CureVac N.V. | 1.05B | 3.32% | 1,546,727 | 83.00M |
| 152 | ABCL | AbCellera Biologics Inc. | 1.03B | 0.29% | 4,756,249 | 35.33M |
| 153 | ERAS | Erasca, Inc. | 1.02B | -3.49% | 3,445,093 | - |
| 154 | IOVA | Iovance Biotherapeutics, Inc. | 1.00B | -7.69% | 15,146,600 | 250.43M |
| 155 | GLUE | Monte Rosa Therapeutics, Inc. | 996.95M | -2.36% | 424,976 | 181.54M |
| 156 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 983.06M | -1.84% | 196,801 | - |
| 157 | MDXG | MiMedx Group, Inc. | 959.70M | -4.28% | 808,999 | 393.44M |
| 158 | CRMD | CorMedix Inc. | 958.07M | 4.56% | 2,156,358 | 214.30M |
| 159 | ALMS | Alumis Inc. | 934.84M | -8.25% | 976,223 | 22.12M |
| 160 | ELVN | Enliven Therapeutics, Inc. | 922.26M | 0.91% | 490,599 | - |
| 161 | TBPH | Theravance Biopharma, Inc. | 919.70M | -2.99% | 544,578 | 80.33M |
| 162 | CMPX | Compass Therapeutics, Inc. | 919.55M | -3.72% | 1,439,860 | 850.00K |
| 163 | ABUS | Arbutus Biopharma Corporation | 917.39M | -0.83% | 1,604,635 | 14.61M |
| 164 | DAWN | Day One Biopharmaceuticals, Inc. | 908.68M | -5.04% | 1,462,289 | 133.67M |
| 165 | IVA | Inventiva S.A. | 907.59M | 2.37% | 201,935 | 19.93M |
| 166 | KURA | Kura Oncology, Inc. | 899.33M | -0.53% | 866,123 | 104.03M |
| 167 | BCAX | Bicara Therapeutics Inc. | 897.33M | -2.67% | 269,410 | - |
| 168 | NKTR | Nektar Therapeutics | 883.23M | 2.70% | 715,608 | 62.60M |
| 169 | RAPT | RAPT Therapeutics, Inc. | 882.59M | -5.96% | 260,720 | - |
| 170 | MRVI | Maravai LifeSciences Holdings, Inc. | 869.40M | 4.62% | 688,442 | 192.44M |
| 171 | AVBP | ArriVent BioPharma, Inc. | 858.65M | 3.38% | 397,425 | - |
| 172 | MLTX | MoonLake Immunotherapeutics | 852.91M | -9.33% | 2,087,154 | - |
| 173 | GERN | Geron Corporation | 842.63M | - | 5,655,030 | 183.40M |
| 174 | VIR | Vir Biotechnology, Inc. | 826.40M | -1.49% | 1,224,290 | 16.86M |
| 175 | YDES | YD Bio Limited | 822.74M | -4.02% | 29,218 | 510.36K |
| 176 | GHRS | GH Research PLC | 821.27M | 4.25% | 891,084 | - |
| 177 | JANX | Janux Therapeutics, Inc. | 821.02M | -1.09% | 1,535,119 | 10.00M |
| 178 | ORIC | ORIC Pharmaceuticals, Inc. | 795.67M | -0.12% | 805,545 | - |
| 179 | KALV | KalVista Pharmaceuticals, Inc. | 781.45M | -4.27% | 1,065,617 | 1.43M |
| 180 | VALN | Valneva SE | 769.44M | 1.59% | 10,570 | 211.09M |
| 181 | DBVT | DBV Technologies S.A. | 769.34M | -0.63% | 377,655 | 5.50M |
| 182 | RIGL | Rigel Pharmaceuticals, Inc. | 759.27M | -2.33% | 678,941 | 282.08M |
| 183 | NBY | NovaBay Pharmaceuticals, Inc. | 739.68M | 4.08% | 452,743 | 10.30M |
| 184 | ARVN | Arvinas, Inc. | 736.65M | -3.29% | 922,337 | 312.30M |
| 185 | ATXS | Astria Therapeutics, Inc. | 735.82M | -1.53% | 383,197 | 706.00K |
| 186 | MPLT | MapLight Therapeutics, Inc. | 733.18M | -4.38% | 230,788 | - |
| 187 | FULC | Fulcrum Therapeutics, Inc. | 720.40M | -3.45% | 796,076 | 80.00M |
| 188 | CTMX | CytomX Therapeutics, Inc. | 720.10M | -0.23% | 2,807,645 | 113.63M |
| 189 | LXEO | Lexeo Therapeutics, Inc. | 701.41M | -3.22% | 1,164,407 | - |
| 190 | ANNX | Annexon, Inc. | 699.07M | -6.57% | 2,102,591 | - |
| 191 | REPL | Replimune Group, Inc. | 698.15M | -8.44% | 1,216,195 | - |
| 192 | RGNX | REGENXBIO Inc. | 686.96M | -5.76% | 1,326,971 | 161.32M |
| 193 | PROK | ProKidney Corp. | 670.86M | -0.45% | 1,858,896 | 744.00K |
| 194 | GOSS | Gossamer Bio, Inc. | 666.59M | -7.10% | 3,853,483 | 44.05M |
| 195 | DRUG | Bright Minds Biosciences Inc. | 656.87M | 6.95% | 311,241 | - |
| 196 | JBIO | Jade Biosciences, Inc. | 651.42M | -8.23% | 237,236 | - |
| 197 | MGTX | MeiraGTx Holdings plc | 628.63M | -1.76% | 396,023 | 27.42M |
| 198 | PRME | Prime Medicine, Inc. | 624.94M | 1.73% | 3,178,593 | 5.98M |
| 199 | SLS | SELLAS Life Sciences Group, Inc. | 619.62M | 15.38% | 30,423,750 | - |
| 200 | GYRE | Gyre Therapeutics, Inc. | 618.96M | -3.54% | 61,297 | 107.27M |
| 201 | LYEL | Lyell Immunopharma, Inc. | 614.90M | -5.85% | 133,065 | 41.00K |
| 202 | VTYX | Ventyx Biosciences, Inc. | 599.41M | -6.98% | 1,221,361 | - |
| 203 | CGEM | Cullinan Therapeutics, Inc. | 597.85M | -2.22% | 800,385 | - |
| 204 | ENGN | enGene Holdings Inc. | 592.81M | -1.99% | 127,420 | - |
| 205 | IVVD | Invivyd, Inc. | 582.81M | 1.21% | 2,777,533 | 50.04M |
| 206 | KROS | Keros Therapeutics, Inc. | 564.84M | -8.94% | 543,597 | 246.72M |
| 207 | VSTM | Verastem, Inc. | 558.02M | -6.35% | 1,253,258 | 13.38M |
| 208 | CRVS | Corvus Pharmaceuticals, Inc. | 546.67M | -4.94% | 1,330,376 | - |
| 209 | EVMN | Evommune, Inc. | 545.68M | 1.11% | 312,609 | 13.00M |
| 210 | ABSI | Absci Corporation | 542.84M | 3.44% | 3,605,257 | 2.82M |
| 211 | ASMB | Assembly Biosciences, Inc. | 533.75M | -0.78% | 82,149 | 37.19M |
| 212 | DSGN | Design Therapeutics, Inc. | 517.80M | -3.09% | 220,081 | - |
| 213 | LBRX | LB Pharmaceuticals Inc | 517.11M | -8.18% | 603,402 | - |
| 214 | ANRO | Alto Neuroscience, Inc. | 515.39M | -6.80% | 237,110 | - |
| 215 | KYTX | Kyverna Therapeutics, Inc. | 501.03M | -6.70% | 1,288,978 | - |
| 216 | LENZ | LENZ Therapeutics, Inc. | 500.64M | - | 527,595 | 17.50M |
| 217 | NAGE | Niagen Bioscience, Inc. | 500.56M | -1.73% | 652,690 | 124.71M |
| 218 | AUTL | Autolus Therapeutics plc | 497.69M | -6.03% | 2,369,192 | 51.13M |
| 219 | PRTA | Prothena Corporation plc | 495.24M | -3.66% | 526,545 | 11.79M |
| 220 | DNA | Ginkgo Bioworks Holdings, Inc. | 494.48M | 4.69% | 918,365 | 180.61M |
| 221 | PEPG | PepGen Inc. | 492.92M | 10.14% | 1,986,987 | - |
| 222 | NBP | NovaBridge Biosciences | 492.29M | 7.29% | 911,910 | - |
| 223 | VTVT | vTv Therapeutics Inc. | 491.39M | -0.88% | 23,201 | 17.00K |
| 224 | VNDA | Vanda Pharmaceuticals Inc. | 487.55M | -6.46% | 4,925,196 | 212.07M |
| 225 | ZVRA | Zevra Therapeutics, Inc. | 469.52M | -6.92% | 941,203 | 84.39M |
| 226 | BCYC | Bicycle Therapeutics plc | 463.38M | -5.65% | 288,582 | 28.34M |
| 227 | VOR | Vor Biopharma Inc. | 450.70M | -11.01% | 1,175,971 | - |
| 228 | TENX | Tenax Therapeutics, Inc. | 448.30M | -9.35% | 85,426 | - |
| 229 | MNPR | Monopar Therapeutics Inc. | 441.12M | 1.09% | 447,679 | - |
| 230 | ADCT | ADC Therapeutics SA | 436.05M | -0.28% | 1,411,444 | 75.21M |
| 231 | OCGN | Ocugen, Inc. | 431.00M | 2.22% | 2,573,180 | 5.37M |
| 232 | IMRX | Immuneering Corporation | 427.45M | 0.61% | 927,309 | - |
| 233 | BNTC | Benitec Biopharma Inc. | 426.16M | -6.57% | 216,726 | - |
| 234 | SLDB | Solid Biosciences Inc. | 424.61M | -3.37% | 1,212,318 | - |
| 235 | IMMP | Immutep Limited | 423.82M | 3.15% | 158,669 | 3.31M |
| 236 | FBRX | Forte Biosciences, Inc. | 421.00M | -13.42% | 203,291 | - |
| 237 | FDMT | 4D Molecular Therapeutics, Inc. | 418.23M | -2.40% | 1,032,474 | 120.00K |
| 238 | ENTA | Enanta Pharmaceuticals, Inc. | 415.91M | -8.62% | 354,270 | 65.32M |
| 239 | LXRX | Lexicon Pharmaceuticals, Inc. | 414.27M | -0.87% | 902,099 | 70.86M |
| 240 | CYBN | Cybin Inc. | 413.20M | 1.22% | 716,450 | - |
| 241 | DMAC | DiaMedica Therapeutics Inc. | 412.97M | -0.38% | 150,162 | - |
| 242 | DRTS | Alpha Tau Medical Ltd. | 411.83M | -2.42% | 185,674 | - |
| 243 | PRTC | PureTech Health plc | 406.25M | 3.19% | 389 | 6.39M |
| 244 | LCTX | Lineage Cell Therapeutics, Inc. | 397.42M | -1.80% | 724,741 | 10.82M |
| 245 | TECX | Tectonic Therapeutic, Inc. | 391.36M | 0.24% | 143,093 | - |
| 246 | EPRX | Eupraxia Pharmaceuticals Inc. | 385.91M | 0.26% | 144,411 | - |
| 247 | RCKT | Rocket Pharmaceuticals, Inc. | 374.45M | -1.42% | 1,335,490 | - |
| 248 | PALI | Palisade Bio, Inc. | 372.51M | 6.38% | 5,571,036 | - |
| 249 | ALT | Altimmune, Inc. | 366.24M | -2.77% | 3,565,519 | 20.00K |
| 250 | ZURA | Zura Bio Limited | 360.88M | 5.92% | 1,247,171 | - |
| 251 | TRDA | Entrada Therapeutics, Inc. | 360.41M | -2.24% | 217,779 | 61.52M |
| 252 | CLLS | Cellectis S.A. | 358.06M | -0.83% | 100,185 | 82.55M |
| 253 | XOMA | XOMA Royalty Corporation | 346.60M | 5.27% | 708,531 | 47.11M |
| 254 | XFOR | X4 Pharmaceuticals, Inc. | 339.25M | -3.00% | 340,316 | 33.98M |
| 255 | AURA | Aura Biosciences, Inc. | 336.57M | -2.75% | 131,547 | - |
| 256 | ACIU | AC Immune SA | 332.45M | 7.01% | 459,651 | 5.48M |
| 257 | CTNM | Contineum Therapeutics, Inc. | 332.39M | -0.35% | 213,220 | - |
| 258 | AVXL | Anavex Life Sciences Corp. | 328.80M | 3.37% | 1,554,051 | - |
| 259 | RLMD | Relmada Therapeutics, Inc. | 320.47M | -9.52% | 983,334 | - |
| 260 | NGNE | Neurogene Inc. | 312.27M | -2.14% | 102,897 | 925.00K |
| 261 | ACRS | Aclaris Therapeutics, Inc. | 312.03M | -4.32% | 1,288,407 | 15.74M |
| 262 | AVTX | Avalo Therapeutics, Inc. | 308.64M | -6.28% | 307,105 | 192.00K |
| 263 | GUTS | Fractyl Health, Inc. | 308.35M | 2.27% | 1,732,619 | 3.00K |
| 264 | ALLO | Allogene Therapeutics, Inc. | 303.39M | -1.46% | 2,313,232 | 22.00K |
| 265 | CADL | Candel Therapeutics, Inc. | 298.65M | -3.72% | 647,072 | - |
| 266 | LRMR | Larimar Therapeutics, Inc. | 297.00M | -8.92% | 1,421,364 | - |
| 267 | FHTX | Foghorn Therapeutics Inc. | 293.22M | -3.98% | 91,772 | 24.52M |
| 268 | PBYI | Puma Biotechnology, Inc. | 291.26M | -2.86% | 394,110 | 212.00M |
| 269 | SLN | Silence Therapeutics plc | 290.49M | 1.15% | 255,374 | 25.83M |
| 270 | TARA | Protara Therapeutics, Inc. | 288.30M | 0.94% | 417,549 | - |
| 271 | ABEO | Abeona Therapeutics Inc. | 287.76M | 0.76% | 1,122,124 | 400.00K |
| 272 | AARD | Aardvark Therapeutics, Inc. | 287.19M | 0.46% | 80,158 | - |
| 273 | IMMX | Immix Biopharma, Inc. | 286.14M | 3.82% | 605,916 | - |
| 274 | NMRA | Neumora Therapeutics, Inc. | 282.10M | -7.26% | 1,982,319 | - |
| 275 | CAMP | Camp4 Therapeutics Corporation | 281.29M | -2.12% | 107,715 | 3.80M |
| 276 | ALDX | Aldeyra Therapeutics, Inc. | 280.96M | -9.85% | 1,116,461 | - |
| 277 | AVIR | Atea Pharmaceuticals, Inc. | 271.88M | -2.52% | 334,703 | - |
| 278 | OABI | OmniAb, Inc. | 270.64M | 1.62% | 278,349 | 21.09M |
| 279 | GLSI | Greenwich LifeSciences, Inc. | 269.75M | -7.33% | 406,961 | - |
| 280 | IKT | Inhibikase Therapeutics, Inc. | 266.73M | -4.88% | 298,402 | 1.00 |
| 281 | ACHV | Achieve Life Sciences, Inc. | 264.57M | - | 552,054 | - |
| 282 | FENC | Fennec Pharmaceuticals Inc. | 262.30M | -0.26% | 131,159 | 38.79M |
| 283 | MENS | Jyong Biotech Ltd. | 262.23M | -13.67% | 668,720 | - |
| 284 | GALT | Galectin Therapeutics Inc. | 261.11M | -2.64% | 542,702 | - |
| 285 | OBIO | Orchestra BioMed Holdings, Inc. | 243.36M | 3.86% | 169,826 | 2.82M |
| 286 | NAUT | Nautilus Biotechnology, Inc. | 241.24M | -2.05% | 129,944 | - |
| 287 | ARMP | Armata Pharmaceuticals, Inc. | 238.83M | 4.46% | 25,915 | 5.05M |
| 288 | MDWD | MediWound Ltd. | 236.17M | -0.22% | 65,321 | 20.93M |
| 289 | STTK | Shattuck Labs, Inc. | 234.77M | 1.64% | 395,497 | 1.00M |
| 290 | HRTX | Heron Therapeutics, Inc. | 231.04M | -3.08% | 2,301,037 | 155.10M |
| 291 | OVID | Ovid Therapeutics Inc. | 229.12M | 7.98% | 1,843,734 | 6.61M |
| 292 | PRLD | Prelude Therapeutics Incorporated | 224.95M | -5.86% | 359,838 | 10.50M |
| 293 | VYGR | Voyager Therapeutics, Inc. | 224.07M | 2.54% | 316,662 | 31.32M |
| 294 | NVCT | Nuvectis Pharma, Inc. | 217.98M | 12.72% | 140,307 | - |
| 295 | CBIO | Crescent Biopharma, Inc. | 216.61M | -6.58% | 97,028 | - |
| 296 | CABA | Cabaletta Bio, Inc. | 212.75M | 0.91% | 1,201,370 | - |
| 297 | PRQR | ProQR Therapeutics N.V. | 209.64M | -1.49% | 209,331 | 18.86M |
| 298 | MIST | Milestone Pharmaceuticals Inc. | 208.24M | 1.49% | 2,228,085 | - |
| 299 | RZLT | Rezolute, Inc. | 200.76M | -8.26% | 4,053,387 | - |
| 300 | EDIT | Editas Medicine, Inc. | 200.12M | - | 2,071,330 | 46.38M |
| 301 | TNXP | Tonix Pharmaceuticals Holding Corp. | 194.90M | 5.95% | 569,537 | 10.30M |
| 302 | SGMT | Sagimet Biosciences Inc. | 194.80M | 1.18% | 396,299 | - |
| 303 | TLSA | Tiziana Life Sciences Ltd | 190.12M | 7.38% | 151,306 | - |
| 304 | HUMA | Humacyte, Inc. | 188.17M | 1.51% | 4,300,003 | 1.57M |
| 305 | CCCC | C4 Therapeutics, Inc. | 187.04M | 1.05% | 973,670 | 30.11M |
| 306 | SRZN | Surrozen, Inc. | 184.71M | -4.65% | 27,587 | 3.60M |
| 307 | SABS | SAB Biotherapeutics, Inc. | 179.48M | 0.80% | 108,294 | 114.70K |
| 308 | CRDF | Cardiff Oncology, Inc. | 179.18M | -5.34% | 598,269 | 501.00K |
| 309 | CLYM | Climb Bio, Inc. | 179.04M | -6.25% | 1,135,905 | - |
| 310 | ARCT | Arcturus Therapeutics Holdings Inc. | 177.58M | 1.96% | 424,371 | 97.60M |
| 311 | RNAC | Cartesian Therapeutics, Inc. | 175.13M | -6.59% | 216,120 | 1.09M |
| 312 | IPHA | Innate Pharma S.A. | 174.96M | 5.71% | 16,631 | 14.84M |
| 313 | NTHI | NeOnc Technologies Holdings, Inc. | 172.93M | 7.38% | 28,858 | 59.99K |
| 314 | GNLX | Genelux Corporation | 171.16M | 4.36% | 73,771 | 8.00K |
| 315 | QNCX | Quince Therapeutics, Inc. | 167.04M | -10.45% | 513,220 | - |
| 316 | ALEC | Alector, Inc. | 167.00M | -1.92% | 637,335 | 69.05M |
| 317 | CHRS | Coherus Oncology, Inc. | 165.59M | -3.52% | 648,636 | 277.73M |
| 318 | RANI | Rani Therapeutics Holdings, Inc. | 165.27M | 0.74% | 1,267,217 | 1.20M |
| 319 | MOLN | Molecular Partners AG | 160.13M | -3.18% | 1,331 | 856.30K |
| 320 | KLRS | Kalaris Therapeutics, Inc. | 155.23M | -1.66% | 94,000 | - |
| 321 | CRBU | Caribou Biosciences, Inc. | 148.61M | - | 880,049 | 9.30M |
| 322 | SGMO | Sangamo Therapeutics, Inc. | 147.59M | 4.43% | 2,533,383 | 32.88M |
| 323 | IRD | Opus Genetics, Inc. | 146.20M | 5.47% | 836,860 | 14.63M |
| 324 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 145.82M | -3.32% | 222,475 | - |
| 325 | CDXS | Codexis, Inc. | 145.42M | -1.23% | 981,748 | 52.93M |
| 326 | MRSN | Mersana Therapeutics, Inc. | 145.16M | 0.38% | 104,075 | 33.18M |
| 327 | CGEN | Compugen Ltd. | 144.98M | 1.31% | 422,541 | 6.90M |
| 328 | CNTX | Context Therapeutics Inc. | 142.41M | 5.44% | 1,011,893 | - |
| 329 | BDTX | Black Diamond Therapeutics, Inc. | 141.87M | 2.47% | 822,704 | 70.00M |
| 330 | ACOG | Alpha Cognition Inc. | 141.32M | - | 24,652 | 7.43M |
| 331 | CNTB | Connect Biopharma Holdings Limited | 140.88M | -10.64% | 82,446 | 762.00K |
| 332 | ELTX | Elicio Therapeutics, Inc. | 140.67M | 1.13% | 72,694 | - |
| 333 | ACTU | Actuate Therapeutics, Inc. | 140.16M | -1.47% | 59,850 | - |
| 334 | PLX | Protalix BioTherapeutics, Inc. | 139.93M | -3.33% | 590,008 | 61.84M |
| 335 | TTRX | Turn Therapeutics Inc. | 138.10M | 19.04% | 155,435 | - |
| 336 | MCRB | Seres Therapeutics, Inc. | 137.05M | 1.81% | 26,314 | 351.00K |
| 337 | NKTX | Nkarta, Inc. | 132.83M | 1.08% | 407,523 | - |
| 338 | VRCA | Verrica Pharmaceuticals Inc. | 132.72M | -0.12% | 71,146 | 30.83M |
| 339 | SPRO | Spero Therapeutics, Inc. | 132.40M | 0.86% | 246,658 | 40.55M |
| 340 | CGTX | Cognition Therapeutics, Inc. | 129.76M | 8.89% | 877,286 | - |
| 341 | ATRA | Atara Biotherapeutics, Inc. | 128.13M | -1.77% | 111,214 | 151.93M |
| 342 | DWTX | Dogwood Therapeutics, Inc. | 126.05M | 1.92% | 22,378 | - |
| 343 | FBIO | Fortress Biotech, Inc. | 125.08M | 10.11% | 1,800,714 | 62.30M |
| 344 | UNCY | Unicycive Therapeutics, Inc. | 124.65M | 0.52% | 345,000 | - |
| 345 | KPTI | Karyopharm Therapeutics Inc. | 122.60M | -2.31% | 141,513 | 142.53M |
| 346 | ABOS | Acumen Pharmaceuticals, Inc. | 122.36M | -4.27% | 145,836 | - |
| 347 | TNYA | Tenaya Therapeutics, Inc. | 122.33M | 3.26% | 2,160,122 | - |
| 348 | GANX | Gain Therapeutics, Inc. | 122.31M | -1.24% | 560,395 | - |
| 349 | ELDN | Eledon Pharmaceuticals, Inc. | 121.74M | 7.28% | 679,315 | - |
| 350 | THAR | Tharimmune, Inc. | 118.45M | 11.55% | 1,108,546 | - |
| 351 | COYA | Coya Therapeutics, Inc. | 118.22M | -2.59% | 291,274 | 3.99M |
| 352 | SLGL | Sol-Gel Technologies Ltd. | 117.42M | 0.02% | 17,471 | 18.97M |
| 353 | INO | Inovio Pharmaceuticals, Inc. | 116.11M | -2.87% | 1,883,592 | 182.34K |
| 354 | ORMP | Oramed Pharmaceuticals Inc. | 115.83M | 2.11% | 83,574 | 2.00M |
| 355 | WHWK | Whitehawk Therapeutics, Inc. | 114.99M | 0.83% | 91,817 | 14.38M |
| 356 | FATE | Fate Therapeutics, Inc. | 113.78M | 0.39% | 969,130 | 7.14M |
| 357 | RPTX | Repare Therapeutics Inc. | 110.79M | -1.15% | 918,560 | 11.87M |
| 358 | AGEN | Agenus Inc. | 109.85M | 2.87% | 356,885 | 106.83M |
| 359 | ONCY | Oncolytics Biotech Inc. | 105.85M | 12.55% | 668,142 | - |
| 360 | ANIX | Anixa Biosciences, Inc. | 104.02M | 1.28% | 76,204 | - |
| 361 | ARTV | Artiva Biotherapeutics, Inc. | 103.82M | -1.40% | 131,712 | 251.00K |
| 362 | SEER | Seer, Inc. | 102.38M | -0.82% | 204,657 | 16.38M |
| 363 | CBUS | Cibus, Inc. | 102.05M | 8.05% | 254,060 | 3.79M |
| 364 | MGNX | MacroGenics, Inc. | 101.85M | - | 894,398 | 127.63M |
| 365 | SAVA | Cassava Sciences, Inc. | 100.96M | 5.56% | 598,907 | - |
| 366 | DTIL | Precision BioSciences, Inc. | 98.69M | -1.44% | 261,410 | 698.00K |
| 367 | CALC | CalciMedica, Inc. | 97.12M | 2.28% | 150,853 | - |
| 368 | SPRB | Spruce Biosciences, Inc. | 97.08M | 4.12% | 25,005 | 697.00K |
| 369 | ETHZ | ETHZilla Corporation | 96.76M | 4.29% | 724,536 | 4.11M |
| 370 | ANVS | Annovis Bio, Inc. | 96.74M | 5.49% | 469,462 | - |
| 371 | BMEA | Biomea Fusion, Inc. | 94.74M | 8.06% | 674,466 | - |
| 372 | HYFT | MindWalk Holdings Corp. | 94.32M | 10.99% | 407,264 | 19.02M |
| 373 | STRO | Sutro Biopharma, Inc. | 93.37M | -5.27% | 69,894 | 105.65M |
| 374 | EQ | Equillium, Inc. | 93.17M | -1.29% | 743,596 | 4.39M |
| 375 | VANI | Vivani Medical, Inc. | 92.65M | 3.25% | 96,013 | - |
| 376 | CSBR | Champions Oncology, Inc. | 92.48M | -3.62% | 1,924 | 58.42M |
| 377 | EXOZ | eXoZymes, Inc. | 92.48M | 1.16% | 695 | -700.00 |
| 378 | PTHS | Pelthos Therapeutics Inc. | 90.90M | -5.00% | 21,277 | 7.41M |
| 379 | ACET | Adicet Bio, Inc. | 89.14M | 4.75% | 732,052 | - |
| 380 | ZNTL | Zentalis Pharmaceuticals, Inc. | 88.71M | 1.48% | 473,978 | 26.87M |
| 381 | VXRT | Vaxart, Inc. | 87.45M | 5.19% | 342,130 | 148.20M |
| 382 | IPSC | Century Therapeutics, Inc. | 86.87M | 0.01% | 1,943,724 | 113.34M |
| 383 | ADAG | Adagene Inc. | 86.72M | -2.65% | 5,257 | 103.20K |
| 384 | OKYO | OKYO Pharma Limited | 83.87M | 7.73% | 210,091 | - |
| 385 | ATOS | Atossa Therapeutics, Inc. | 81.46M | 6.88% | 1,547,295 | - |
| 386 | MREO | Mereo BioPharma Group plc | 81.22M | 22.49% | 58,242,937 | 500.00K |
| 387 | ENTX | Entera Bio Ltd. | 81.17M | -8.76% | 157,268 | 124.00K |
| 388 | COEP | Coeptis Therapeutics Holdings, Inc. | 78.18M | 2.74% | 48,224 | 501.00K |
| 389 | ACRV | Acrivon Therapeutics, Inc. | 77.63M | 2.07% | 311,972 | - |
| 390 | NRXP | NRx Pharmaceuticals, Inc. | 77.57M | -3.32% | 702,326 | 242.00K |
| 391 | PLRX | Pliant Therapeutics, Inc. | 76.81M | 2.46% | 803,850 | - |
| 392 | TIL | Instil Bio, Inc. | 76.43M | 2.45% | 66,390 | - |
| 393 | PSTV | Plus Therapeutics, Inc. | 76.27M | 8.33% | 2,783,206 | 5.26M |
| 394 | KRRO | Korro Bio, Inc. | 75.81M | 0.50% | 149,951 | 7.37M |
| 395 | ATYR | aTyr Pharma, Inc. | 74.38M | -3.06% | 1,157,653 | 190.00K |
| 396 | IFRX | InflaRx N.V. | 73.84M | 7.92% | 690,711 | 73.73K |
| 397 | IMA | ImageneBio, Inc. | 73.39M | -0.14% | 18,713 | 800.00K |
| 398 | XBIT | XBiotech Inc. | 72.56M | -0.42% | 24,327 | - |
| 399 | PYPD | PolyPid Ltd. | 72.36M | 0.23% | 42,704 | - |
| 400 | TVGN | Tevogen Bio Holdings Inc. | 72.28M | 9.88% | 445,273 | - |
| 401 | CRVO | CervoMed Inc. | 72.08M | -1.39% | 39,082 | 6.16M |
| 402 | PYXS | Pyxis Oncology, Inc. | 71.60M | - | 1,079,144 | 2.82M |
| 403 | IMUX | Immunic, Inc. | 70.13M | 9.24% | 1,389,789 | - |
| 404 | BYSI | BeyondSpring Inc. | 66.21M | -1.23% | 86,564 | 1.88M |
| 405 | ATHE | Alterity Therapeutics Limited | 65.46M | 2.60% | 2,947 | 3.57M |
| 406 | PMVP | PMV Pharmaceuticals, Inc. | 65.45M | -1.60% | 108,569 | - |
| 407 | MNOV | MediciNova, Inc. | 65.36M | 1.53% | 41,591 | 257.92K |
| 408 | MGX | Metagenomi, Inc. | 62.70M | 3.09% | 211,052 | 30.91M |
| 409 | ALXO | ALX Oncology Holdings Inc. | 62.35M | 1.77% | 121,959 | - |
| 410 | MAIA | MAIA Biotechnology, Inc. | 61.23M | 4.58% | 834,616 | - |
| 411 | RADX | Radiopharm Theranostics Limited | 59.12M | -1.15% | 60,401 | 8.20M |
| 412 | TCRX | TScan Therapeutics, Inc. | 57.88M | 2.00% | 348,603 | 8.42M |
| 413 | LITS | Lite Strategy, Inc. | 56.65M | 16.67% | 783,198 | - |
| 414 | GRCE | Grace Therapeutics, Inc. | 56.63M | 5.78% | 89,804 | - |
| 415 | ALGS | Aligos Therapeutics, Inc. | 56.18M | -2.04% | 18,064 | 2.65M |
| 416 | KZIA | Kazia Therapeutics Limited | 54.48M | -27.43% | 360,144 | 1.20M |
| 417 | IBO | Impact BioMedical Inc. | 54.25M | 2.67% | 86,739 | 25.00K |
| 418 | NTRB | Nutriband Inc. | 53.85M | -2.42% | 22,979 | 2.28M |
| 419 | ICCC | ImmuCell Corporation | 53.55M | -3.74% | 66,877 | 27.77M |
| 420 | ESLA | Estrella Immunopharma, Inc. | 52.87M | -10.26% | 20,725 | - |
| 421 | INKT | MiNK Therapeutics, Inc. | 52.20M | -0.27% | 6,786 | - |
| 422 | ABVC | ABVC BioPharma, Inc. | 51.62M | 2.82% | 52,567 | 797.92K |
| 423 | JSPR | Jasper Therapeutics, Inc. | 51.49M | 0.55% | 382,250 | - |
| 424 | ANL | Adlai Nortye Ltd. | 50.92M | -2.82% | 132,971 | -1.35M |
| 425 | IOBT | IO Biotech, Inc. | 48.28M | 10.22% | 600,300 | - |
| 426 | NRXS | NeurAxis, Inc. | 47.51M | -1.76% | 82,064 | 3.36M |
| 427 | OSTX | OS Therapies Incorporated | 47.19M | -4.29% | 477,991 | - |
| 428 | PTN | Palatin Technologies, Inc. | 47.18M | 4.36% | 21,615 | 8.85M |
| 429 | ANEB | Anebulo Pharmaceuticals, Inc. | 46.43M | 11.88% | 55,405 | - |
| 430 | NXTC | NextCure, Inc. | 46.24M | -7.05% | 63,980 | - |
| 431 | TELO | Telomir Pharmaceuticals, Inc. | 46.07M | 0.75% | 276,077 | - |
| 432 | KZR | Kezar Life Sciences, Inc. | 46.06M | - | 6,851 | - |
| 433 | PDSB | PDS Biotechnology Corporation | 45.59M | 8.24% | 321,767 | - |
| 434 | HURA | TuHURA Biosciences, Inc. | 45.51M | -0.95% | 196,015 | - |
| 435 | IBIO | iBio, Inc. | 45.42M | 4.66% | 1,418,282 | 500.00K |
| 436 | LPCN | Lipocine Inc. | 44.42M | -0.37% | 271,440 | 4.32M |
| 437 | ATNM | Actinium Pharmaceuticals, Inc. | 42.74M | 0.74% | 129,389 | 90.00K |
| 438 | QTTB | Q32 Bio Inc. | 42.33M | 3.61% | 145,837 | - |
| 439 | OTLK | Outlook Therapeutics, Inc. | 42.32M | -58.23% | 83,398,973 | 1.41M |
| 440 | APLM | Apollomics, Inc. | 41.42M | 3.24% | 30,671 | 6.93M |
| 441 | CVM | CEL-SCI Corporation | 41.28M | -2.09% | 47,765 | - |
| 442 | INMB | INmune Bio, Inc. | 40.94M | -1.28% | 466,810 | 50.00K |
| 443 | OKUR | OnKure Therapeutics, Inc. | 40.10M | 2.07% | 19,325 | - |
| 444 | EVAX | Evaxion A/S | 39.28M | -1.26% | 63,813 | 7.65M |
| 445 | TVRD | Tvardi Therapeutics, Inc. | 38.28M | -5.12% | 137,907 | - |
| 446 | BTAI | BioXcel Therapeutics, Inc. | 37.18M | 6.25% | 479,137 | 752.00K |
| 447 | PASG | Passage Bio, Inc. | 37.16M | -0.93% | 27,522 | - |
| 448 | FGEN | FibroGen, Inc. | 37.06M | 4.33% | 28,233 | 8.30M |
| 449 | GBIO | Generation Bio Co. | 36.69M | -4.14% | 133,750 | 15.27M |
| 450 | VERU | Veru Inc. | 36.43M | 6.07% | 102,705 | 16.89M |
| 451 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 35.67M | 11.11% | 6,471,388 | - |
| 452 | XCUR | Exicure, Inc. | 35.57M | 2.95% | 27,311 | 500.00K |
| 453 | XLO | Xilio Therapeutics, Inc. | 35.26M | 4.92% | 377,297 | 31.80M |
| 454 | GLTO | Galecto, Inc. | 34.81M | -5.17% | 49,489 | - |
| 455 | LTRN | Lantern Pharma Inc. | 34.78M | 2.64% | 100,181 | - |
| 456 | JUNS | Jupiter Neurosciences, Inc. | 34.77M | -0.98% | 32,630 | - |
| 457 | CELU | Celularity Inc. | 34.28M | 9.01% | 37,707 | 40.58M |
| 458 | DYAI | Dyadic International, Inc. | 34.01M | -0.01% | 134,732 | 3.34M |
| 459 | GNTA | Genenta Science S.p.A. | 33.04M | -5.37% | 164,955 | - |
| 460 | RNTX | Rein Therapeutics Inc. | 32.86M | 7.76% | 174,696 | - |
| 461 | BCAB | BioAtla, Inc. | 31.54M | -5.90% | 2,022,548 | 11.00M |
| 462 | HOWL | Werewolf Therapeutics, Inc. | 31.30M | 1.78% | 346,614 | 1.14M |
| 463 | CUE | Cue Biopharma, Inc. | 30.78M | 10.48% | 7,010,299 | 7.10M |
| 464 | RNXT | RenovoRx, Inc. | 30.61M | -0.58% | 220,378 | 928.00K |
| 465 | ANTX | AN2 Therapeutics, Inc. | 30.42M | -2.63% | 22,707 | - |
| 466 | BRNS | Barinthus Biotherapeutics plc | 30.01M | 4.99% | 28,720 | 14.97M |
| 467 | RLYB | Rallybio Corporation | 29.88M | 3.09% | 55,873 | 674.00K |
| 468 | CING | Cingulate Inc. | 29.60M | 0.92% | 121,646 | - |
| 469 | HYPD | Hyperion DeFi, Inc. | 29.26M | 0.56% | 219,251 | 345.32K |
| 470 | QNTM | Quantum BioPharma Ltd. | 29.23M | -3.97% | 68,814 | - |
| 471 | SNTI | Senti Biosciences, Inc. | 28.92M | 5.77% | 242,100 | - |
| 472 | SKYE | Skye Bioscience, Inc. | 28.15M | 17.14% | 407,958 | - |
| 473 | DARE | Daré Bioscience, Inc. | 27.86M | 1.04% | 73,715 | -57.13K |
| 474 | PLUR | Pluri Inc. | 27.58M | - | 9,093 | 1.33M |
| 475 | ATHA | Athira Pharma, Inc. | 27.45M | -8.06% | 186,628 | - |
| 476 | NERV | Minerva Neurosciences, Inc. | 27.41M | -2.49% | 37,798 | - |
| 477 | BOLD | Boundless Bio, Inc. | 27.31M | 1.67% | 108,618 | - |
| 478 | IGC | IGC Pharma, Inc. | 27.02M | 3.41% | 403,529 | 1.11M |
| 479 | VTGN | Vistagen Therapeutics, Inc. | 26.82M | 2.58% | 2,002,886 | 721.00K |
| 480 | KTTA | Pasithea Therapeutics Corp. | 26.65M | -7.75% | 258,451 | - |
| 481 | MRKR | Marker Therapeutics, Inc. | 25.68M | 3.36% | 234,517 | 4.69M |
| 482 | PLRZ | Polyrizon Ltd. | 25.17M | 50.18% | 1,199,871 | - |
| 483 | CANF | Can-Fite BioPharma Ltd. | 24.66M | 10.00% | 2,776,719 | 560.00K |
| 484 | INTS | Intensity Therapeutics, Inc. | 24.45M | -0.78% | 1,097,246 | - |
| 485 | NNVC | NanoViricides, Inc. | 23.63M | 7.08% | 300,824 | - |
| 486 | KLTO | Klotho Neurosciences, Inc. | 23.18M | 10.55% | 608,140 | - |
| 487 | LNAI | Lunai Bioworks Inc. | 22.77M | 10.20% | 150,875 | - |
| 488 | SER | Serina Therapeutics, Inc. | 22.16M | 8.63% | 15,757 | 116.00K |
| 489 | LIXT | Lixte Biotechnology Holdings, Inc. | 21.90M | -2.29% | 79,064 | - |
| 490 | MTVA | MetaVia Inc. | 21.04M | 13.54% | 21,085 | - |
| 491 | NEUP | Neuphoria Therapeutics Inc. | 20.54M | -1.55% | 31,227 | 15.65M |
| 492 | NRSN | NeuroSense Therapeutics Ltd. | 19.53M | 1.42% | 211,205 | - |
| 493 | VYNE | VYNE Therapeutics Inc. | 19.30M | -0.03% | 507,685 | 524.00K |
| 494 | CLGN | CollPlant Biotechnologies Ltd. | 18.91M | 5.71% | 22,964 | 2.48M |
| 495 | ENLV | Enlivex Therapeutics Ltd. | 18.34M | 7.35% | 396,906 | - |
| 496 | ALLR | Allarity Therapeutics, Inc. | 18.01M | 5.56% | 187,908 | - |
| 497 | CTXR | Citius Pharmaceuticals, Inc. | 17.61M | 9.14% | 426,342 | - |
| 498 | LIMN | Liminatus Pharma, Inc. | 17.34M | 5.03% | 62,485 | - |
| 499 | GRDX | GridAI Technologies Corp. | 17.28M | 10.30% | 358,034 | - |
| 500 | CVKD | Cadrenal Therapeutics, Inc. | 17.14M | 8.11% | 67,574 | - |
| 501 | CASI | CASI Pharmaceuticals, Inc. | 16.90M | -3.26% | 10,666 | 26.85M |
| 502 | LSTA | Lisata Therapeutics, Inc. | 16.85M | 5.38% | 48,143 | 1.07M |
| 503 | ITRM | Iterum Therapeutics plc | 16.60M | -6.12% | 1,290,170 | 390.00K |
| 504 | HOTH | Hoth Therapeutics, Inc. | 16.60M | 8.08% | 440,007 | - |
| 505 | LEXX | Lexaria Bioscience Corp. | 16.28M | 6.00% | 379,537 | 705.92K |
| 506 | GDTC | CytoMed Therapeutics Limited | 16.04M | 4.12% | 5,770 | 573.19K |
| 507 | FBLG | FibroBiologics, Inc. | 15.96M | 6.67% | 4,501,191 | - |
| 508 | PMN | ProMIS Neurosciences, Inc. | 15.36M | 4.54% | 8,012 | - |
| 509 | KAPA | Kairos Pharma, Ltd. | 15.19M | 2.72% | 80,496 | - |
| 510 | NCNA | NuCana plc | 15.15M | 1.11% | 55,453 | - |
| 511 | OSRH | OSR Holdings, Inc. | 15.13M | 4.49% | 407,492 | -90.52K |
| 512 | APLT | Applied Therapeutics, Inc. | 14.82M | 2.70% | 4,942,851 | 1.00M |
| 513 | ASBP | Aspire Biopharma Holdings, Inc. | 14.71M | 3.79% | 19,947,850 | 1.94K |
| 514 | CLRB | Cellectar Biosciences, Inc. | 14.71M | 17.63% | 86,269 | - |
| 515 | TPST | Tempest Therapeutics, Inc. | 14.54M | 2.79% | 84,287 | - |
| 516 | SNGX | Soligenix, Inc. | 14.32M | 5.97% | 189,721 | 2.34K |
| 517 | SYBX | Synlogic, Inc. | 13.69M | 4.46% | 21,531 | 8.00K |
| 518 | COCP | Cocrystal Pharma, Inc. | 13.68M | 1.41% | 34,374 | - |
| 519 | BCDA | BioCardia, Inc. | 13.48M | 1.60% | 54,552 | 3.00K |
| 520 | BCTX | BriaCell Therapeutics Corp. | 13.47M | 0.84% | 75,985 | - |
| 521 | AKTX | Akari Therapeutics, Plc | 13.28M | 0.35% | 428,560 | - |
| 522 | AEON | AEON Biopharma, Inc. | 13.14M | 0.91% | 178,422 | - |
| 523 | CRIS | Curis, Inc. | 12.71M | -0.42% | 114,850 | 11.65M |
| 524 | LGVN | Longeveron Inc. | 12.65M | 17.19% | 515,118 | 1.44M |
| 525 | EDSA | Edesa Biotech, Inc. | 12.50M | 5.63% | 32,464 | - |
| 526 | BLRX | BioLineRx Ltd. | 12.29M | 1.08% | 26,219 | 12.74M |
| 527 | SNSE | Sensei Biotherapeutics, Inc. | 12.17M | -9.61% | 858,573 | - |
| 528 | IMNN | Imunon, Inc. | 12.13M | 3.67% | 83,598 | - |
| 529 | QNRX | Quoin Pharmaceuticals, Ltd. | 11.81M | -2.43% | 20,403 | - |
| 530 | PHIO | Phio Pharmaceuticals Corp. | 11.73M | 3.81% | 403,272 | - |
| 531 | ABP | Abpro Holdings, Inc. | 11.46M | -0.24% | 6,522 | 183.00K |
| 532 | INAB | IN8bio, Inc. | 11.40M | 5.13% | 258,629 | - |
| 533 | MBRX | Moleculin Biotech, Inc. | 11.15M | 9.37% | 149,127 | - |
| 534 | BOLT | Bolt Biotherapeutics, Inc. | 11.11M | 5.89% | 27,926 | 5.20M |
| 535 | CMMB | Chemomab Therapeutics Ltd. | 11.02M | 8.48% | 77,096 | - |
| 536 | BRTX | BioRestorative Therapies, Inc. | 10.83M | 3.83% | 26,653 | 383.40K |
| 537 | TRAW | Traws Pharma, Inc. | 10.63M | 17.70% | 205,095 | 2.85M |
| 538 | BIVI | BioVie Inc. | 10.02M | 14.66% | 252,010 | - |
| 539 | NCEL | NewcelX Ltd. | 9.53M | 10.00% | 27,700 | - |
| 540 | ICU | SeaStar Medical Holding Corporation | 9.48M | 9.63% | 1,029,326 | 881.00K |
| 541 | EVGN | Evogene Ltd. | 9.15M | 2.73% | 36,069 | 8.02M |
| 542 | ERNA | Ernexa Therapeutics Inc. | 9.10M | -3.33% | 14,022 | 1,000.00 |
| 543 | APVO | Aptevo Therapeutics Inc. | 8.79M | -0.42% | 107,151 | - |
| 544 | APM | Aptorum Group Limited | 8.71M | 0.94% | 33,097 | - |
| 545 | TOVX | Theriva Biologics, Inc. | 8.70M | 22.62% | 13,915,999 | - |
| 546 | GTBP | GT Biopharma, Inc. | 8.69M | 4.06% | 1,429,777 | - |
| 547 | CLDI | Calidi Biotherapeutics, Inc. | 8.63M | 0.85% | 35,490 | - |
| 548 | PULM | Pulmatrix, Inc. | 8.25M | 1.35% | 33,527 | 3.00K |
| 549 | ADXN | Addex Therapeutics Ltd | 8.17M | 4.79% | 485 | 198.82K |
| 550 | MBIO | Mustang Bio, Inc. | 7.81M | 9.07% | 91,201 | - |
| 551 | PPCB | Propanc Biopharma, Inc. | 7.64M | 6.54% | 64,382 | - |
| 552 | IMRN | Immuron Limited | 7.62M | 4.26% | 27,756 | 4.78M |
| 553 | PMCB | PharmaCyte Biotech, Inc. | 7.48M | 1.93% | 147,638 | - |
| 554 | KPRX | Kiora Pharmaceuticals, Inc. | 7.41M | 2.54% | 23,505 | 20.00K |
| 555 | TCRT | Alaunos Therapeutics, Inc. | 7.32M | 1.55% | 37,104 | 6.00K |
| 556 | ALZN | Alzamend Neuro, Inc. | 7.22M | 4.40% | 29,957 | - |
| 557 | PPBT | Purple Biotech Ltd | 7.00M | 0.44% | 120,128 | - |
| 558 | BGMS | Bio Green Med Solution, Inc. | 6.91M | -4.73% | 34,621 | 81.00K |
| 559 | CELZ | Creative Medical Technology Holdings, Inc. | 6.88M | 0.51% | 91,920 | 6.00K |
| 560 | RNAZ | TransCode Therapeutics, Inc. | 6.79M | 8.35% | 21,276 | - |
| 561 | KALA | KALA BIO, Inc. | 6.66M | 11.73% | 815,017 | - |
| 562 | PCSA | Processa Pharmaceuticals, Inc. | 6.64M | 1.74% | 107,426 | - |
| 563 | XTLB | XTL Biopharmaceuticals Ltd. | 6.53M | 3.36% | 329,001 | 968.00K |
| 564 | ADIL | Adial Pharmaceuticals, Inc. | 6.38M | 8.77% | 248,568 | - |
| 565 | GOVX | GeoVax Labs, Inc. | 6.15M | 21.05% | 6,565,189 | 3.35M |
| 566 | SLXN | Silexion Therapeutics Corp | 5.88M | -2.08% | 43,659 | - |
| 567 | ACXP | Acurx Pharmaceuticals, Inc. | 5.76M | 10.84% | 63,108 | - |
| 568 | LYRA | Lyra Therapeutics, Inc. | 5.61M | 2.60% | 11,427 | 600.00K |
| 569 | APRE | Aprea Therapeutics, Inc. | 5.38M | - | 55,362 | 488.24K |
| 570 | CDIO | Cardio Diagnostics Holdings, Inc. | 5.19M | 4.80% | 11,064 | 15.78K |
| 571 | CYCN | Cyclerion Therapeutics, Inc. | 5.10M | 5.51% | 10,870 | 2.86M |
| 572 | XBIO | Xenetic Biosciences, Inc. | 4.93M | -0.92% | 17,127 | 2.86M |
| 573 | VIVS | VivoSim Labs, Inc. | 4.90M | 3.87% | 15,737 | 140.00K |
| 574 | REVB | Revelation Biosciences, Inc. | 4.82M | 1.68% | 77,925 | - |
| 575 | INDP | Indaptus Therapeutics, Inc. | 4.80M | -5.84% | 170,370 | - |
| 576 | SPRC | SciSparc Ltd. | 4.59M | 2.94% | 153,209 | 1.31M |
| 577 | JAGX | Jaguar Health, Inc. | 4.53M | 7.12% | 232,538 | 11.79M |
| 578 | GLMD | Galmed Pharmaceuticals Ltd. | 4.51M | 9.65% | 108,485 | - |
| 579 | SILO | Silo Pharma, Inc. | 4.47M | -1.29% | 126,781 | 72.10K |
| 580 | SLRX | Salarius Pharmaceuticals, Inc. | 4.16M | 0.49% | 536,424 | - |
| 581 | GNPX | Genprex, Inc. | 4.15M | 2.29% | 204,719 | - |
| 582 | XRTX | XORTX Therapeutics Inc. | 4.06M | 1.42% | 35,022 | - |
| 583 | MTNB | Matinas BioPharma Holdings, Inc. | 3.97M | 5.80% | 3,801 | - |
| 584 | ENVB | Enveric Biosciences, Inc. | 3.76M | 1.10% | 43,190 | - |
| 585 | OGEN | Oragenics, Inc. | 3.48M | 6.61% | 53,048 | - |
| 586 | ENSC | Ensysce Biosciences, Inc. | 3.41M | 2.17% | 52,170 | 4.49M |
| 587 | CNSP | CNS Pharmaceuticals, Inc. | 3.29M | 0.95% | 8,937 | - |
| 588 | PHGE | BiomX Inc. | 3.27M | 14.44% | 34,373 | - |
| 589 | HCWB | HCW Biologics Inc. | 3.03M | 15.39% | 46,691 | 422.03K |
| 590 | AZTR | Azitra, Inc. | 2.99M | 5.25% | 667,272 | 7.50K |
| 591 | CMND | Clearmind Medicine Inc. | 2.98M | 9.94% | 64,935 | - |
| 592 | GRI | GRI Bio, Inc. | 2.83M | 13.45% | 2,924,924 | - |
| 593 | ARTL | Artelo Biosciences, Inc. | 2.56M | 4.10% | 20,648 | - |
| 594 | VRAX | Virax Biolabs Group Limited | 2.51M | 11.05% | 319,876 | 2.99K |
| 595 | ONCO | Onconetix, Inc. | 2.50M | 3.21% | 27,701 | 1.22M |
| 596 | CDT | CDT Equity Inc. | 2.35M | 12.50% | 119,718 | - |
| 597 | SCNI | Scinai Immunotherapeutics Ltd. | 2.33M | 2.44% | 11,406 | 1.15M |
| 598 | DRMA | Dermata Therapeutics, Inc. | 2.24M | -6.03% | 606,973 | - |
| 599 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.18M | 1.50% | 156,210 | 1.36M |
| 600 | BDRX | Biodexa Pharmaceuticals Plc | 1.68M | 8.37% | 122,021 | 104.90K |
| 601 | ADTX | Aditxt, Inc. | 1.57M | 6.00% | 310,012 | 5.95K |
| 602 | PBM | Psyence Biomedical Ltd. | 1.50M | 6.05% | 222,791 | - |
| 603 | PTIX | Protagenic Therapeutics, Inc. | 1.43M | -43.08% | 1,922,073 | - |
| 604 | MLEC | Moolec Science SA | 1.11M | 8.41% | 1,362,575 | 7.83M |
| 605 | ELAB | PMGC Holdings Inc. | 1.06M | -4.05% | 485,717 | 285.95K |